Akzo Nobel India Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: May 24, 2025, 1:59 pm

Market Cap	16,376 Cr.
Current Price	3,596
High / Low	4,674/2,469
Stock P/E	38.2
Book Value	292
Dividend Yield	2.09 %
ROCE	41.7 %
ROE	32.2 %
Face Value	10.0
PEG Ratio	2.45

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Akzo Nobel India Ltd

Competitors of Akzo Nobel India Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Sirca Paints India Ltd	1,726 Cr.	315	386/231	35.2	63.8	0.48 %	19.9 %	14.9 %	10.0
Shalimar Paints Ltd	860 Cr.	103	163/91.4		41.4	0.00 %	12.6 %	20.2 %	2.00
Kansai Nerolac Paints Ltd	21,037 Cr.	260	321/218	33.0	79.4	0.96 %	14.0 %	10.6 %	1.00
Berger Paints India Ltd	64,696 Cr.	555	630/438	54.8	52.8	0.63 %	25.1 %	20.5 %	1.00
Akzo Nobel India Ltd	16,376 Cr.	3,596	4,674/2,469	38.2	292	2.09 %	41.7 %	32.2 %	10.0
Industry Average	54,466.17 Cr	1,190.83		43.54	121.90	0.87%	23.17%	19.83%	4.17

All Competitor Stocks of Akzo Nobel India Ltd

Quarterly Result

Metric	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Sales	914	867	938	926	987	951	999	956	1,033	973	1,036	982	1,050
Expenses	786	748	817	820	844	797	837	814	866	812	867	836	884
Operating Profit	128	119	121	106	143	155	162	142	166	162	169	146	167
OPM %	14%	14%	13%	11%	14%	16%	16%	15%	16%	17%	16%	15%	16%
Other Income	5	7	4	5	12	6	8	9	8	10	10	9	6
Interest	3	6	2	3	3	6	3	3	3	3	2	2	3
Depreciation	19	19	19	20	21	22	19	21	20	22	22	22	23
Profit before tax	110	101	104	88	132	133	148	127	152	147	154	132	146
Tax %	24%	26%	26%	26%	26%	28%	26%	26%	25%	26%	26%	26%	26%
Net Profit	84	75	77	65	97	95	110	94	114	109	115	98	109
EPS in Rs	18.40	16.38	16.89	14.36	21.39	20.95	24.13	20.68	24.99	23.89	25.16	21.50	23.85

Last Updated: February 28, 2025, 8:43 pm

Below is a detailed analysis of the quarterly data for Akzo Nobel India Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

For Sales, as of Dec 2024, the value is 1,050.00 Cr.. The value appears strong and on an upward trend. It has increased from 982.00 Cr. (Sep 2024) to 1,050.00 Cr., marking an increase of 68.00 Cr..
For Expenses, as of Dec 2024, the value is 884.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 836.00 Cr. (Sep 2024) to 884.00 Cr., marking an increase of 48.00 Cr..
For Operating Profit, as of Dec 2024, the value is 167.00 Cr.. The value appears strong and on an upward trend. It has increased from 146.00 Cr. (Sep 2024) to 167.00 Cr., marking an increase of 21.00 Cr..
For OPM %, as of Dec 2024, the value is 16.00%. The value appears strong and on an upward trend. It has increased from 15.00% (Sep 2024) to 16.00%, marking an increase of 1.00%.
For Other Income, as of Dec 2024, the value is 6.00 Cr.. The value appears to be declining and may need further review. It has decreased from 9.00 Cr. (Sep 2024) to 6.00 Cr., marking a decrease of 3.00 Cr..
For Interest, as of Dec 2024, the value is 3.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.00 Cr. (Sep 2024) to 3.00 Cr., marking an increase of 1.00 Cr..
For Depreciation, as of Dec 2024, the value is 23.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 22.00 Cr. (Sep 2024) to 23.00 Cr., marking an increase of 1.00 Cr..
For Profit before tax, as of Dec 2024, the value is 146.00 Cr.. The value appears strong and on an upward trend. It has increased from 132.00 Cr. (Sep 2024) to 146.00 Cr., marking an increase of 14.00 Cr..
For Tax %, as of Dec 2024, the value is 26.00%. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 26.00%.
For Net Profit, as of Dec 2024, the value is 109.00 Cr.. The value appears strong and on an upward trend. It has increased from 98.00 Cr. (Sep 2024) to 109.00 Cr., marking an increase of 11.00 Cr..
For EPS in Rs, as of Dec 2024, the value is 23.85. The value appears strong and on an upward trend. It has increased from 21.50 (Sep 2024) to 23.85, marking an increase of 2.35.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: May 15, 2025, 7:21 am

Metric	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Sales	2,332	2,442	2,640	2,572	2,719	2,918	2,662	2,421	3,149	3,802	3,962	4,091
Expenses	2,141	2,181	2,380	2,244	2,420	2,576	2,291	2,078	2,714	3,276	3,328	3,450
Operating Profit	192	261	260	329	300	342	370	343	434	526	633	641
OPM %	8%	11%	10%	13%	11%	12%	14%	14%	14%	14%	16%	16%
Other Income	57	68	110	65	240	43	41	21	23	26	35	28
Interest	2	2	2	3	4	4	9	10	14	14	12	10
Depreciation	44	53	54	54	58	65	79	76	76	82	82	89
Profit before tax	203	275	314	337	478	316	323	278	367	456	573	570
Tax %	26%	32%	32%	27%	16%	33%	27%	25%	21%	26%	26%	25%
Net Profit	150	186	214	247	401	211	237	208	290	335	427	429
EPS in Rs	32.19	39.93	45.91	52.94	85.85	46.33	52.13	45.59	63.68	73.58	93.70	94.11
Dividend Payout %	233%	50%	153%	42%	26%	52%	27%	110%	118%	88%	80%	106%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2014-2015	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024	2024-2025
YoY Net Profit Growth (%)	24.00%	15.05%	15.42%	62.35%	-47.38%	12.32%	-12.24%	39.42%	15.52%	27.46%	0.47%
Change in YoY Net Profit Growth (%)	0.00%	-8.95%	0.37%	46.93%	-109.73%	59.70%	-24.56%	51.66%	-23.91%	11.95%	-26.99%

Akzo Nobel India Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:	5%
5 Years:	9%
3 Years:	9%
TTM:	3%

Compounded Profit Growth
10 Years:	11%
5 Years:	13%
3 Years:	14%
TTM:	0%

Stock Price CAGR
10 Years:	10%
5 Years:	15%
3 Years:	28%
1 Year:	40%

Return on Equity
10 Years:	24%
5 Years:	26%
3 Years:	30%
Last Year:	32%

Last Updated: Unknown

Balance Sheet

Last Updated: March 14, 2025, 4:10 pm

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
Equity Capital	47	47	47	47	47	47	46	46	46	46	46	46	46
Reserves	1,059	801	873	1,116	962	1,244	1,090	1,192	1,242	1,213	1,270	1,284	1,380
Borrowings	0	0	0	3	3	3	3	64	64	70	70	60	64
Other Liabilities	1,200	1,191	879	878	872	938	959	1,024	1,178	1,261	1,354	1,513	1,676
Total Liabilities	2,305	2,039	1,799	2,043	1,884	2,231	2,097	2,325	2,529	2,590	2,739	2,903	3,166
Fixed Assets	355	502	516	523	519	539	530	574	543	520	511	526	562
CWIP	106	31	12	9	23	27	17	16	16	42	73	119	92
Investments	947	629	394	600	336	573	377	84	0	0	0	0	0
Other Assets	898	877	876	911	1,006	1,092	1,173	1,652	1,969	2,029	2,156	2,258	2,511
Total Assets	2,305	2,039	1,799	2,043	1,884	2,231	2,097	2,325	2,529	2,590	2,739	2,903	3,166

Below is a detailed analysis of the balance sheet data for Akzo Nobel India Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

For Equity Capital, as of Sep 2024, the value is 46.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 46.00 Cr..
For Reserves, as of Sep 2024, the value is 1,380.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,284.00 Cr. (Mar 2024) to 1,380.00 Cr., marking an increase of 96.00 Cr..
For Borrowings, as of Sep 2024, the value is 64.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 60.00 Cr. (Mar 2024) to 64.00 Cr., marking an increase of 4.00 Cr..
For Other Liabilities, as of Sep 2024, the value is 1,676.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,513.00 Cr. (Mar 2024) to 1,676.00 Cr., marking an increase of 163.00 Cr..
For Total Liabilities, as of Sep 2024, the value is 3,166.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,903.00 Cr. (Mar 2024) to 3,166.00 Cr., marking an increase of 263.00 Cr..
For Fixed Assets, as of Sep 2024, the value is 562.00 Cr.. The value appears strong and on an upward trend. It has increased from 526.00 Cr. (Mar 2024) to 562.00 Cr., marking an increase of 36.00 Cr..
For CWIP, as of Sep 2024, the value is 92.00 Cr.. The value appears to be declining and may need further review. It has decreased from 119.00 Cr. (Mar 2024) to 92.00 Cr., marking a decrease of 27.00 Cr..
For Investments, as of Sep 2024, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
For Other Assets, as of Sep 2024, the value is 2,511.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,258.00 Cr. (Mar 2024) to 2,511.00 Cr., marking an increase of 253.00 Cr..
For Total Assets, as of Sep 2024, the value is 3,166.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,903.00 Cr. (Mar 2024) to 3,166.00 Cr., marking an increase of 263.00 Cr..

Notably, the Reserves (1,380.00 Cr.) exceed the Borrowings (64.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity +	171	155	263	143	181	141	375	283	121	486	486	311
Cash from Investing Activity +	250	239	-156	225	-6	185	4	-225	230	-15	-87	123
Cash from Financing Activity +	-438	-410	-113	-392	-126	-360	-157	-174	-346	-302	-439	-460
Net Cash Flow	-17	-16	-6	-24	50	-34	222	-116	6	170	-41	-26

Free Cash Flow

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Free Cash Flow	192.00	261.00	257.00	326.00	297.00	339.00	306.00	279.00	364.00	456.00	573.00	641.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	43	48	42	49	58	53	56	54	62	57	53	53
Inventory Days	89	86	95	89	107	84	85	107	135	129	95	100
Days Payable	135	130	119	145	164	159	131	171	220	164	138	164
Cash Conversion Cycle	-3	4	17	-7	1	-22	9	-10	-23	22	11	-10
Working Capital Days	-67	-62	-12	-59	15	10	20	-3	-12	16	5	-1
ROCE %	15%	16%	25%	26%	27%	40%	24%	27%	22%	28%	35%	42%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Promoters	74.76%	74.76%	74.76%	74.76%	74.76%	74.76%	74.76%	74.76%	74.76%	74.76%	74.76%	74.76%
FIIs	1.66%	1.75%	2.12%	2.71%	2.97%	3.15%	3.14%	3.20%	3.42%	3.63%	3.75%	3.84%
DIIs	10.50%	10.37%	9.61%	9.21%	8.99%	8.75%	8.61%	8.56%	8.36%	8.28%	8.11%	8.05%
Public	13.09%	13.12%	13.51%	13.33%	13.27%	13.34%	13.49%	13.49%	13.47%	13.33%	13.39%	13.35%
No. of Shareholders	45,780	45,746	45,880	43,940	43,735	45,231	46,657	47,322	46,712	46,662	45,906	48,266

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund Name	No of Shares	AUM (%)	Amount Invested (Cr)	Previous Number of Shares	Previous Date	Percentage Change
Aditya Birla Sun Life Frontline Equity Fund	737,914	0.72	219.59	737,914	2025-04-22 17:25:43	0%
HDFC Childrens Gift Fund - Regular Plan	457,021	1.39	136	457,021	2025-04-22 15:57:00	0%
Tata Large & Mid Cap Fund - Regular Plan	181,800	0.65	54.1	181,800	2025-04-22 15:57:00	0%
Tata Large & Mid Cap Fund - Regular Plan	181,800	0.65	54.1	181,800	2025-04-22 17:25:43	0%
Templeton India Equity Income Fund	115,000	1.36	34.22	115,000	2025-04-22 15:57:00	0%
UTI Dividend Yield Fund	107,000	0.73	31.84	107,000	2025-04-22 17:25:43	0%
Aditya Birla Sun Life Midcap Fund	86,364	0.42	25.7	86,364	2025-04-22 15:57:00	0%
Aditya Birla Sun Life MNC Fund - Div	72,601	0.52	21.61	72,601	2025-04-22 15:57:00	0%
Aditya Birla Sun Life MNC Fund - Gr	72,601	0.52	21.61	72,601	2025-04-22 15:57:00	0%
Templeton India Value Fund	60,000	0.79	17.86	60,000	2025-04-22 17:25:43	0%

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	93.68	73.58	63.70	45.60	52.13
Diluted EPS (Rs.)	93.68	73.58	63.70	45.60	52.13
Cash EPS (Rs.)	111.85	91.78	80.44	62.22	69.39
Book Value[Excl.RevalReserv]/Share (Rs.)	292.02	289.03	276.55	282.88	271.23
Book Value[Incl.RevalReserv]/Share (Rs.)	292.29	289.30	276.81	283.14	271.49
Revenue From Operations / Share (Rs.)	870.68	835.63	692.00	532.17	583.73
PBDIT / Share (Rs.)	146.77	121.43	100.04	80.00	91.38
PBIT / Share (Rs.)	128.68	103.30	83.36	63.41	74.06
PBT / Share (Rs.)	125.93	100.20	80.61	61.14	70.88
Net Profit / Share (Rs.)	93.76	73.65	63.76	45.63	52.06
NP After MI And SOA / Share (Rs.)	93.76	73.65	63.76	45.63	52.06
PBDIT Margin (%)	16.85	14.53	14.45	15.03	15.65
PBIT Margin (%)	14.77	12.36	12.04	11.91	12.68
PBT Margin (%)	14.46	11.99	11.64	11.48	12.14
Net Profit Margin (%)	10.76	8.81	9.21	8.57	8.91
NP After MI And SOA Margin (%)	10.76	8.81	9.21	8.57	8.91
Return on Networth / Equity (%)	32.10	25.48	23.05	16.12	19.19
Return on Capital Employeed (%)	39.55	31.82	26.94	20.05	24.50
Return On Assets (%)	14.69	12.22	11.19	8.20	10.20
Asset Turnover Ratio (%)	1.40	1.43	1.23	0.99	1.20
Current Ratio (X)	1.35	1.48	1.49	1.60	1.64
Quick Ratio (X)	0.92	1.00	0.92	1.15	1.19
Inventory Turnover Ratio (X)	3.32	3.30	3.08	2.56	2.94
Dividend Payout Ratio (NP) (%)	96.08	81.52	109.89	74.56	55.51
Dividend Payout Ratio (CP) (%)	80.54	65.42	87.10	54.68	41.65
Earning Retention Ratio (%)	3.92	18.48	-9.89	25.44	44.49
Cash Earning Retention Ratio (%)	19.46	34.58	12.90	45.32	58.35
Interest Coverage Ratio (X)	53.42	39.18	31.39	35.34	44.81
Interest Coverage Ratio (Post Tax) (X)	35.13	24.77	20.87	21.16	27.09
Enterprise Value (Cr.)	10323.76	9851.79	8249.97	9768.88	9482.65
EV / Net Operating Revenue (X)	2.61	2.59	2.62	4.03	3.56
EV / EBITDA (X)	15.46	17.83	18.12	26.84	22.76
MarketCap / Net Operating Revenue (X)	2.74	2.74	2.77	4.34	3.77
Retention Ratios (%)	3.91	18.47	-9.89	25.43	44.48
Price / BV (X)	8.16	7.92	6.92	8.16	8.11
Price / Net Operating Revenue (X)	2.74	2.74	2.77	4.34	3.77
EarningsYield	0.03	0.03	0.03	0.01	0.02

After reviewing the key financial ratios for Akzo Nobel India Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
For Basic EPS (Rs.), as of Mar 24, the value is 93.68. This value is within the healthy range. It has increased from 73.58 (Mar 23) to 93.68, marking an increase of 20.10.
For Diluted EPS (Rs.), as of Mar 24, the value is 93.68. This value is within the healthy range. It has increased from 73.58 (Mar 23) to 93.68, marking an increase of 20.10.
For Cash EPS (Rs.), as of Mar 24, the value is 111.85. This value is within the healthy range. It has increased from 91.78 (Mar 23) to 111.85, marking an increase of 20.07.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 292.02. It has increased from 289.03 (Mar 23) to 292.02, marking an increase of 2.99.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 292.29. It has increased from 289.30 (Mar 23) to 292.29, marking an increase of 2.99.
For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 870.68. It has increased from 835.63 (Mar 23) to 870.68, marking an increase of 35.05.
For PBDIT / Share (Rs.), as of Mar 24, the value is 146.77. This value is within the healthy range. It has increased from 121.43 (Mar 23) to 146.77, marking an increase of 25.34.
For PBIT / Share (Rs.), as of Mar 24, the value is 128.68. This value is within the healthy range. It has increased from 103.30 (Mar 23) to 128.68, marking an increase of 25.38.
For PBT / Share (Rs.), as of Mar 24, the value is 125.93. This value is within the healthy range. It has increased from 100.20 (Mar 23) to 125.93, marking an increase of 25.73.
For Net Profit / Share (Rs.), as of Mar 24, the value is 93.76. This value is within the healthy range. It has increased from 73.65 (Mar 23) to 93.76, marking an increase of 20.11.
For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 93.76. This value is within the healthy range. It has increased from 73.65 (Mar 23) to 93.76, marking an increase of 20.11.
For PBDIT Margin (%), as of Mar 24, the value is 16.85. This value is within the healthy range. It has increased from 14.53 (Mar 23) to 16.85, marking an increase of 2.32.
For PBIT Margin (%), as of Mar 24, the value is 14.77. This value is within the healthy range. It has increased from 12.36 (Mar 23) to 14.77, marking an increase of 2.41.
For PBT Margin (%), as of Mar 24, the value is 14.46. This value is within the healthy range. It has increased from 11.99 (Mar 23) to 14.46, marking an increase of 2.47.
For Net Profit Margin (%), as of Mar 24, the value is 10.76. This value exceeds the healthy maximum of 10. It has increased from 8.81 (Mar 23) to 10.76, marking an increase of 1.95.
For NP After MI And SOA Margin (%), as of Mar 24, the value is 10.76. This value is within the healthy range. It has increased from 8.81 (Mar 23) to 10.76, marking an increase of 1.95.
For Return on Networth / Equity (%), as of Mar 24, the value is 32.10. This value is within the healthy range. It has increased from 25.48 (Mar 23) to 32.10, marking an increase of 6.62.
For Return on Capital Employeed (%), as of Mar 24, the value is 39.55. This value is within the healthy range. It has increased from 31.82 (Mar 23) to 39.55, marking an increase of 7.73.
For Return On Assets (%), as of Mar 24, the value is 14.69. This value is within the healthy range. It has increased from 12.22 (Mar 23) to 14.69, marking an increase of 2.47.
For Asset Turnover Ratio (%), as of Mar 24, the value is 1.40. It has decreased from 1.43 (Mar 23) to 1.40, marking a decrease of 0.03.
For Current Ratio (X), as of Mar 24, the value is 1.35. This value is below the healthy minimum of 1.5. It has decreased from 1.48 (Mar 23) to 1.35, marking a decrease of 0.13.
For Quick Ratio (X), as of Mar 24, the value is 0.92. This value is below the healthy minimum of 1. It has decreased from 1.00 (Mar 23) to 0.92, marking a decrease of 0.08.
For Inventory Turnover Ratio (X), as of Mar 24, the value is 3.32. This value is below the healthy minimum of 4. It has increased from 3.30 (Mar 23) to 3.32, marking an increase of 0.02.
For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 96.08. This value exceeds the healthy maximum of 50. It has increased from 81.52 (Mar 23) to 96.08, marking an increase of 14.56.
For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 80.54. This value exceeds the healthy maximum of 50. It has increased from 65.42 (Mar 23) to 80.54, marking an increase of 15.12.
For Earning Retention Ratio (%), as of Mar 24, the value is 3.92. This value is below the healthy minimum of 40. It has decreased from 18.48 (Mar 23) to 3.92, marking a decrease of 14.56.
For Cash Earning Retention Ratio (%), as of Mar 24, the value is 19.46. This value is below the healthy minimum of 40. It has decreased from 34.58 (Mar 23) to 19.46, marking a decrease of 15.12.
For Interest Coverage Ratio (X), as of Mar 24, the value is 53.42. This value is within the healthy range. It has increased from 39.18 (Mar 23) to 53.42, marking an increase of 14.24.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 35.13. This value is within the healthy range. It has increased from 24.77 (Mar 23) to 35.13, marking an increase of 10.36.
For Enterprise Value (Cr.), as of Mar 24, the value is 10,323.76. It has increased from 9,851.79 (Mar 23) to 10,323.76, marking an increase of 471.97.
For EV / Net Operating Revenue (X), as of Mar 24, the value is 2.61. This value is within the healthy range. It has increased from 2.59 (Mar 23) to 2.61, marking an increase of 0.02.
For EV / EBITDA (X), as of Mar 24, the value is 15.46. This value exceeds the healthy maximum of 15. It has decreased from 17.83 (Mar 23) to 15.46, marking a decrease of 2.37.
For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 2.74. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 2.74.
For Retention Ratios (%), as of Mar 24, the value is 3.91. This value is below the healthy minimum of 30. It has decreased from 18.47 (Mar 23) to 3.91, marking a decrease of 14.56.
For Price / BV (X), as of Mar 24, the value is 8.16. This value exceeds the healthy maximum of 3. It has increased from 7.92 (Mar 23) to 8.16, marking an increase of 0.24.
For Price / Net Operating Revenue (X), as of Mar 24, the value is 2.74. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 2.74.
For EarningsYield, as of Mar 24, the value is 0.03. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 23) which recorded 0.03.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Akzo Nobel India Ltd as of May 24, 2025 is: 2,933.43

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of May 24, 2025, Akzo Nobel India Ltd is Overvalued by 18.43% compared to the current share price 3,596.00

Intrinsic Value of Akzo Nobel India Ltd as of May 24, 2025 is: 3,391.01

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of May 24, 2025, Akzo Nobel India Ltd is Overvalued by 5.70% compared to the current share price 3,596.00

Last 5 Year EPS CAGR: 15.60%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The stock has a high average ROCE of 27.25%, which is a positive sign. The stock has a low average Working Capital Days of -12.50, which is a positive sign. The stock has a low average Cash Conversion Cycle of -0.92, which is a positive sign. The company has higher reserves (1,132.77 cr) compared to borrowings (31.08 cr), indicating strong financial stability. The company has shown consistent growth in sales (2.42 cr) and profit (374.17 cr) over the years.

Strength

Weakness

The stock has a high average ROCE of 27.25%, which is a positive sign.
The stock has a low average Working Capital Days of -12.50, which is a positive sign.
The stock has a low average Cash Conversion Cycle of -0.92, which is a positive sign.
The company has higher reserves (1,132.77 cr) compared to borrowings (31.08 cr), indicating strong financial stability.
The company has shown consistent growth in sales (2.42 cr) and profit (374.17 cr) over the years.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Akzo Nobel India Ltd:
1. Net Profit Margin: 10.76%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 39.55% (Industry Average ROCE: 23.17%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 32.1% (Industry Average ROE: 19.83%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 35.13
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 0.92
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 38.2 (Industry average Stock P/E: 36.28)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Akzo Nobel India Ltd. is a Public Limited Listed company incorporated on 12/03/1954 and has its registered office in the State of West Bengal, India. Company's Corporate Identification Number(CIN) is L24292WB1954PLC021516 and registration number is 021516. Currently Company is involved in the business activities of Manufacture of paints and varnishes, enamels or lacquers. Company's Total Operating Revenue is Rs. 4091.20 Cr. and Equity Capital is Rs. 45.50 Cr. for the Year ended 31/03/2025.

INDUSTRY	ADDRESS	CONTACT
Paints/Varnishes	8-B, Middleton Street, Kolkata West Bengal 700071	investor.india@akzonobel.com http://www.akzonobel.co.in

Management
Name	Position Held
Mr. Rajiv Rajgopal	Chairman & Managing Director
Mr. Krishna Rallapalli	WholeTime Director & CFO
Mr. Rohit G Totla	Whole Time Director
Mr. Hemant Sahai	Independent Director
Ms. Smriti Rekha Vijay	Independent Director
Mr. Amit Jain	Independent Director

FAQ

What is the intrinsic value of Akzo Nobel India Ltd?

Akzo Nobel India Ltd's intrinsic value (as of 24 May 2025) is ₹2933.43 — 18.43% lower the current market price of 3,596.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 16,376 Cr. market cap, FY2025-2026 high/low of ₹4,674/2,469, reserves of 1,380 Cr, and liabilities of 3,166 Cr.

What is the Market Cap of Akzo Nobel India Ltd?

The Market Cap of Akzo Nobel India Ltd is 16,376 Cr..

What is the current Stock Price of Akzo Nobel India Ltd as on 24 May 2025?

The current stock price of Akzo Nobel India Ltd as on 24 May 2025 is 3,596.

What is the High / Low of Akzo Nobel India Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Akzo Nobel India Ltd stocks is ₹4,674/2,469.

What is the Stock P/E of Akzo Nobel India Ltd?

The Stock P/E of Akzo Nobel India Ltd is 38.2.

What is the Book Value of Akzo Nobel India Ltd?

The Book Value of Akzo Nobel India Ltd is 292.

What is the Dividend Yield of Akzo Nobel India Ltd?

The Dividend Yield of Akzo Nobel India Ltd is 2.09 %.

What is the ROCE of Akzo Nobel India Ltd?

The ROCE of Akzo Nobel India Ltd is 41.7 %.

What is the ROE of Akzo Nobel India Ltd?

The ROE of Akzo Nobel India Ltd is 32.2 %.

What is the Face Value of Akzo Nobel India Ltd?

The Face Value of Akzo Nobel India Ltd is 10.0.